Low-dose transdermal scopolamine decreases blood pressure in mild essential hypertension

Journal of Hypertension

Volumn 16, Issue 3, 1998, Pages 321-329

  Vesalainen, Risto K ^a   Kaila, Timo J ^b   Kantola, Ilkka M ^b   Tahvariainen, Kari U O ^c   Airaksinen, K E Juhani ^d   Kuusela, Tom A ^a   Eckberg, Dwain L ^e  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Parasympathetic nervous system; Power spectrum analysis; Transdermal scopolamine

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ADULT; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE; BODY POSITION; CARDIOVASCULAR EFFECT; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FINGER; HEART RATE; HUMAN; HYPERPNEA; MALE; MODULATION; PHOTOELECTRIC PLETHYSMOGRAPHY; POWER SPECTRUM; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RR INTERVAL; SINUS ARRHYTHMIA; SINUS NODE; SPHYGMOMANOMETRY; SPIROMETRY; SUPINE POSITION; TILTING; TRANSDERMAL DRUG ADMINISTRATION; VAGUS TONE;

EID: 0031889476     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816030-00009     Document Type: Article

References (61)

1. Lund-Johansen P. Haemodynamics in essential hypertension. Clin Sci 1980; 59:343-354.
2. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62:347-504.
3. Goldstein DS. Plasma catecholamines and essential hypertension [review]. Hypertension 1983; 5:86-99.
4. Malliani A, Pagani M, Lombardi F, Cerrutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84:482-492.
5. van Zwieten PA. The cholinergic nervous system in hypertension, a neglected issue. Blood Pressure 1992; 1:68-71.
6. Julius S, Pascual AV, London R. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971; 140:982-985.
7. Korner PO, Shaw J, Uther JB, West MJ, McRuckhie RJ, Richards JG. Autonomic and nonautonomic components in essential hypertension in man. Circulation 1973; 48:107-117.
8. Bristow JD, Honour AJ, Pickering GW, Sleight P, Smyth HS. Diminished baroreflex sensitivity in high blood pressure. Circulation 1969; 39:48-54.
9. Eckberg DL. Carotid baroreflex function in young men with borderline blood pressure elevation. Circulation 1979; 59:632-636.
10. Guzzetti S, Piccaluga E, Casati R, Cerutti S, Lombardi F, Pagani M, et al. Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens 1988; 6:711-717.
11. Furlan R, Guzzetti S, Crivellaro W, Dassi S, Tinelli M, Baselli G, el al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and R-R variabilities in ambulant subjects. Circulation 1990; 81:537-547.
12. Langewitz W, Rüddel H, Schächinger H. Reduced parasympathetic cardiac control in patients with hypertension at rest and under mental stress. Am Heart J 1994; 127:122-128.
13. Chakko S, Mullingtapang R, Huikun H, Kessler K, Materson B, Myerburg R. Alterations in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hypertrophy free of coronary artery disease. Am Heart J 1993; 126:1364-1372.
14. van Zwieten PA, Hendriks GC, Pfaffendorf M, Bruning TA, Chang PC. The parasympathetic system and its muscarinic receptors in hypertensive disease. J Hypertens 1995; 13:1079-1090.
15. Weiner N: Atropine, scopolamine, and related antimuscarinic compounds. In: Goodman LS, Gillman AG, Rall TW, Murad F (editors). Goodman and Gilmans's the pharmacological basis ot therapeutics. Seventh edition. New York: Macmillan Publishing Co.; 1985. pp. 130-144.
16. Dibner-Dunlap M, Eckberg D, Magid N, Cintrón-Trevino N. The long-term increase of baseline and reflexly augmented levels of human vagal-cardiac nervous activity induced by scopolamine. Circulation 1985; 71:797-804.
17. Vybiral T, Bryg RJ, Maddens ME, Bhasin SS, Cronin S, Boden WE, et al. Effects of transdermal scopolamine on heart rate variability in normal subjects. Am J Cardiol 1990; 65:604-608.
18. Vesalainen RK, Tahvanainen KUO, Kaila TJ, Kantola IM, Kuusela TA, Eckberg DL. Effects of low-dose transdermal scopolamine on autonomic cardiovascular control in healthy young subjects. Clin Physiol 1997; 17:135-148.
19. Casadei B, Pipilis A, Sessa F, Conway J, Sleight P. Low doses of scopolamine increase cardiac vagal tone in acute phase of myocardial infarction. Circulation 1993; 88:353-357.
20. De Ferrari GM, Mantica M, Vanoli E, Hull SS, Schwartz PJ. Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. J Am Coll Cardiol 1993; 22:1327-1334.
21. Pedretti B, Colombo E, Sarzi-Braga S, Caru B. Influence of transdermal scopolamine on cardiac sympathovagal interaction after acute myocardial infarction. Am J Cardiol 1993; 72:384-392.
22. La Rovere MT, Morteara MD, Pantaleo P, Maestri R, Cobelli F, Tavazzi L. Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation 1994; 90:838-843.
23. Casadei B, Conway J, Forfar C, Sleight P. Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure. Heart 1996; 75:274-280.
24. Guidelines of Sub-committee of World Health Organization/International Society of Hypertension Mild Hypertension Liaison Committee. Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993; 11:905-918.
25. Hartikainen J, Tarkiainen I, Tahvanainen K, Mäntysaari M, Länsimies E, Pyörälä K. Circadian variation of cardiac autonomic regulation during 24-h bed rest. Clin Physiol 1993; 13:185-196.
26. Hartikainen JEK, Tahvanainen KUO, Mäntysaari MJ, Tikkanen PE, Länsimies EA, Airaksinen KEJ. Simultaneous invasive and noninvasive evaluations of baroreflex sensitivity with bolus phenylephrine technique. Am Heart J 1995; 130:296-301.
27. Engelse WAH, Zeelenberg C. A single scan algorithm for QRS detection and feature extraction. In: IEEE Computers in Cardiology. Long Beach, California: IEEE Computer Society; 1979. pp. 37-42.
28. de Boer RW, Karemaker JM, van Montfrans GA. Determination of baroreflex sensitivity by spectral analysis of spontaneous blood-pressure and heart-rate fluctuations in man. In: Lown B, Malliani A, Prosdocimi D (editors). Neural mechanisms and cardiovascular disease. Padova: Liviana; 1986. pp. 303-315.
29. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93:1043-1065.
30. Hughson RL, Quintin L, Annat G, Yamamoto Y, Gharib C. Spontaneous baroreflex by sequence and power spectral methods in humans. Clin Physiol 1993; 13:663-676.
31. Parlow J, Viale JP, Annat G, Hughson R, Quintin L. Spontaneous cardiac baroreflex in humans. Comparison with drug-induced responses. Hypertension 1995; 25:1058-1068.
32. Kaila T, Ali-Melkkilä T, Iisalo E, Kanto J. Radioreceptor assay for pharmacokinetic studies of glycopyrrolate. Pharmacol Toxicol 1990; 67:313-316.
33. Bigger JT Jr, Fleiss JL Steinman RC, Rolnitzky LM, Kleiger RE. Rottman JN. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol 1992; 69:891-898.
34. Jones B, Kenward MG. The 2×2 cross-over trial with continuous data. In: Jones B, Kenward MG (editors). Design and analysis of cross-over trials. London: Chapman and Hall; 1989. pp. 17-87.
35. Somers VK, Conway J, Johnston J, Sleight P. Effects of endurance training on baroreflex sensitivity and blood pressure in borderline hypertension. Lancet 1991; 337:1363-1368.
36. Akselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectral analysis. Am J Physiol 1985; 249:H867-H875.
37. Pomerantz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985; 248:151-153.
38. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and in conscious dog. Circ Res 1986; 59:178-193.
39. Wheeler T, Watkins PJ. Cardiac denervation in diabetes. BMJ 1973; 4:584-586.
40. Iwase S, Mano T, Saito M. Effects of graded head-up tilting on muscle sympathetic activities in man. Physiologist 1987; 30 (suppl) :S62-S65.
41. Mukai S, Hayano J. Heart rate and blood pressure variabilities during graded head-up tilt. J Appl Physiol 1995; 78:212-216.
42. Koh J, Brown TE, Beightol LA, Ha CY, Eckberg DL. Human autonomic rhythms: vagal cardiac mechanisms in tetraplegic subjects. J Physiol Lond 1994; 474:483-495.
43. Porter TR, Eckberg DL, Rea RF, Fritsch JM, Mohanty PK. Autonomic pathophysiology in heart failure: sympathetic-cholinergic interrelations. J Clin Invest 1990; 85:1362-1371.
44. Brown TE, Beightol LA, Koh J, Eckberg DL Important influence of respiration on human R-R interval power spectra is largely ignored. J Appl Physiol 1993; 75:2310-2317.
45. Kaila T, Antila K, Pihlajamäki K, Halkola L Scopolamine plasma levels and the control of heart rate. In: Abstracts of the XIX Nordic congress of physiology and pharmacology. Oslo: University of Oslo; 1988. p. 71.
46. Gilbey MP, Jordan D, Richter DW, Spyer KM. Synaptic mechanisms involved in the inspiratory modulation of vagal cardio-inhibitory neurones in the cat. J Physiol Lond 1984; 356:65-78.
47. Katona PG, Lipson D, Dauchot PJ. Opposing central and peripheral effects of atropine on parasympathetic cardiac control. Am J Physiol 1977; 232:H146-H151.
48. 2-cholinoceptors. Naunyn-Schmiedbergs Arch Pharmacol 1988; 388:19-27.
49. Meyer EC, Sommers K. Possible mechanisms of anticholinergic druginduced bradycardia. Eur J Clin Pharmacol 1988; 74:617-626.
50. 3H-pirenzepine. Drug Res 1985; 35:325-328.
51. Spyer KM. Central nervous control of the cardiovascular system. In: Bannister R, Mathias CJ (editors). Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford: Oxford University Press; 1992. pp. 54-77.
52. Shepherd RFJ, Shepherd JT. Control of blood pressure and circulation in man. In: Bannister R, Mathias CJ (editors). Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford: Oxford University Press; 1992. pp. 78-93.
53. Eckberg DL, Sleight P. Human baroreflexes in health and disease. Oxford: Clarendon Press; 1992. pp. 123-298.
54. Fritch JM, Rea RF, Eckberg DL. Carotid baroreflex resetting during druginduced arterial pressure changes in humans. Am J Physiol 1989; 256:R549-R553.
55. Zelis R, Caudill CC, Baggette K, Mason DT. Reflex vasodilatation induced by coronary angiography in human beings. Circulation 1976; 53:490-493.
56. Shupak A, Gordon O, Spitzer N, Mendelowitz N, Melamed Y. Three-years' experience of transdermal scopolamine: long-term effectiveness and side effects. Pharmacotherapeutica 1989; 5:365-369.
57. Gleiter CH, Antonin KH, Bieck RP. Transdermally applied scopolamine does not impair psychomotor performance. Psychopharmacology 1984; 83:397-398.
58. Parati G, Saul JP, Rienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation, a critical appraisal. Hypertension 1995; 25;1276-1286.
59. Rimoldi O, Pierini S, Ferrari S, Cerutti S, Pagani M, Malliani A. Analysis of short term oscillations of R-R and arterial pressure in conscious dogs. Am J Physiol 1990; 258:H967-H976.
60. Inoue K. Miyake S, Kumashiro H, Ogata H. Ueta T, Akatsu T. Power spectral analysis of blood pressure variability in traumatic quadriplegic humans. Am J Physiol 1991; 260:H842-H847.
61. Hedman AE, Hartikainen JEK, Tahvanainen KUO, Hakumäki MOK. Power spectral analysis of heart rate and blood pressure in anesthetized dogs. Acta Physiol Scand 1992; 146:155-164.